Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole Safety Study in GERD
NCT00216489Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2003
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rabeprazole in gastroesophageal reflux disease (GERD), sponsored by Janssen Pharmaceutical. Started Mar 2003; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00216489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216489.